Role of the early short-course corticosteroids treatment in ARDS caused by COVID-19: A single-center, retrospective analysis

Clicks: 247
ID: 274488
2021
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
The eHDM is an interesting and promising approach in the ARDS related to COVID-19 pneumonia, which reduces mortality, length of hospitalization and the need for mechanical ventilation.
Reference Key
l2021advancesrole Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Boglione L;Olivieri C;Rostagno R;Poletti F;Moglia R;Bianchi B;Esposito M;Biffi S;Borrè S;;
Journal advances in medical sciences
Year 2021
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/34022675
Keywords
respiration National Center for Biotechnology Information NCBI NLM MEDLINE Health Care humans pubmed abstract nih national institutes of health national library of medicine treatment outcome female male aged severity of illness index pneumonia hospital mortality dose-response relationship drug italy / epidemiology adrenal cortex hormones / administration & dosage outcome and process assessment viral* / diagnosis sars-cov-2 / isolation & purification* pmid:34022675 pmc8064826 doi:10.1016/j.advms.2021.04.002 lucio boglione carlo olivieri silvio borrè covid-19* / diagnosis covid-19* / physiopathology covid-19* / therapy duration of therapy early medical intervention / methods lung / diagnostic imaging* methylprednisolone / administration & dosage* viral* / drug therapy viral* / virology artificial / statistics & numerical data respiratory distress syndrome* / diagnosis respiratory distress syndrome* / etiology respiratory distress syndrome* / therapy

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.